ZFIN ID: ZDB-FISH-150901-3034
Fish name: fgf8ati282a/+
Genotype: fgf8ati282a/+
Targeting Reagent: none
HUMAN DISEASE MODELED by fgf8ati282a/+
No data available
GENE EXPRESSION
Gene expression in fgf8ati282a/+
RNA expression
Expressed Gene Structure Conditions Figures
col1a1a standard conditions Fig. 5 from Gebuijs et al., 2019
col1a2 standard conditions Fig. 5 from Gebuijs et al., 2019
col2a1a standard conditions Fig. 5,  Fig. 6. with image from Gebuijs et al., 2019
col9a1a standard conditions Fig. 5 from Gebuijs et al., 2019
col9a1b standard conditions Fig. 5 from Gebuijs et al., 2019
dlx2a standard conditions Fig. 5,  Fig. 6. with image from Gebuijs et al., 2019
dlx3b chemical treatment: SB 431542 Fig. 4 with image from Kwon et al., 2009
egr2b chemical treatment: SB 431542 Fig. 4 with image from Kwon et al., 2009
fgf8a standard conditions Fig. 5,  Fig. 6. with image from Gebuijs et al., 2019
foxi1 standard conditions Fig. 5 with image from Nechiporuk et al., 2007
chemical treatment: SB 431542 Fig. 4 with image from Kwon et al., 2009
fsta chemical treatment: SB 431542 Fig. 4 with image from Kwon et al., 2009
isl1a chemical treatment: SB 431542 Fig. 4 with image from Kwon et al., 2009
nkx3-2 standard conditions Fig. 5 from Gebuijs et al., 2019
pax2a standard conditions Fig. 5 with image from Nechiporuk et al., 2007
chemical treatment: SB 431542 Fig. 4 with image from Kwon et al., 2009
pax8 chemical treatment: SB 431542 Fig. 4 with image,  Fig. 5 with image from Kwon et al., 2009
runx2a standard conditions Fig. 5,  Fig. 6. with image from Gebuijs et al., 2019
runx2b standard conditions Fig. 5 from Gebuijs et al., 2019
shha chemical treatment: SB 431542 Fig. 4 with image from Kwon et al., 2009
sp7 standard conditions Fig. 5 from Gebuijs et al., 2019
Protein expression No data available
Reporter gene expression No data available
PHENOTYPE
Phenotype in fgf8ati282a/+
Phenotype Conditions Figures
branchiostegal ray 1 bone mineralization decreased occurrence, abnormal standard conditions Fig. 4 from Gebuijs et al., 2019
ceratobranchial 5 bone bone mineralization decreased occurrence, abnormal standard conditions Fig. 2. with image,  Fig. 4 from Gebuijs et al., 2019
ceratobranchial 5 tooth bone mineralization decreased occurrence, abnormal standard conditions Fig. 4 from Gebuijs et al., 2019
ceratohyal bone decreased length, abnormal standard conditions Fig. 3 from Gebuijs et al., 2019
chondrocranium bilateral symmetry, abnormal standard conditions Fig. 2 with image from Albertson et al., 2007
cleithrum bone mineralization decreased occurrence, abnormal standard conditions Fig. 4 from Gebuijs et al., 2019
embryonic viscerocranium morphogenesis process quality, normal control Fig. 9 with image from Lovely et al., 2016
embryonic viscerocranium morphogenesis process quality, normal chemical treatment: dorsomorphin Fig. 9 with image from Lovely et al., 2016
entopterygoid bone mineralization decreased occurrence, abnormal standard conditions Fig. 4 from Gebuijs et al., 2019
ethmoid cartilage decreased length, abnormal standard conditions Fig. 3 from Gebuijs et al., 2019
head decreased size, abnormal standard conditions Fig. 2. with image,  Fig. 3 from Gebuijs et al., 2019
head anterior region decreased width, abnormal standard conditions Fig. 3 from Gebuijs et al., 2019
Meckel's cartilage decreased length, abnormal standard conditions Fig. 3 from Gebuijs et al., 2019
Meckel's cartilage-palatoquadrate cartilage joint decreased width, abnormal standard conditions Fig. 3 from Gebuijs et al., 2019
notochord bone mineralization decreased occurrence, abnormal standard conditions Fig. 4 from Gebuijs et al., 2019
opercle bilateral symmetry, abnormal standard conditions Fig. 3 with image from Albertson et al., 2007
opercle malformed, abnormal standard conditions Fig. 3 with image from Albertson et al., 2007
opercle bone mineralization decreased occurrence, abnormal standard conditions Fig. 4 from Gebuijs et al., 2019
otic placode decreased amount, abnormal chemical treatment: SB 431542 Fig. 4 with image from Kwon et al., 2009
otic placode malformed, abnormal chemical treatment: SB 431542 Fig. 4 with image from Kwon et al., 2009
otic placode mislocalised medially, abnormal chemical treatment: SB 431542 Fig. 4 with image from Kwon et al., 2009
otic placode formation process quality, abnormal chemical treatment: SB 431542 Fig. 4 with image from Kwon et al., 2009
otic placode formation process quality, abnormal chemical treatment: SB 431542 Fig. 5 with image from Kwon et al., 2009
otic vesicle decreased amount, abnormal chemical treatment: SB 431542 Fig. 4 with image from Kwon et al., 2009
otic vesicle increased size, abnormal chemical treatment: SB 431542 Fig. 4 with image from Kwon et al., 2009
otic vesicle malformed, abnormal chemical treatment: SB 431542 Fig. 4 with image from Kwon et al., 2009
otic vesicle mislocalised medially, abnormal chemical treatment: SB 431542 Fig. 4 with image from Kwon et al., 2009
otolith bone mineralization decreased occurrence, abnormal standard conditions Fig. 4 from Gebuijs et al., 2019
parasphenoid bone mineralization decreased occurrence, abnormal standard conditions Fig. 2. with image,  Fig. 4 from Gebuijs et al., 2019
paraxial mesoderm mislocalised medially, abnormal chemical treatment: SB 431542 Fig. 4 with image from Kwon et al., 2009
paraxial mesodermal cell fate specification process quality, abnormal chemical treatment: SB 431542 Fig. 5 with image from Kwon et al., 2009
regulation of bone remodeling occurrence, abnormal standard conditions Fig. 5 with image from Albertson et al., 2007
ventral mandibular arch bilateral symmetry, abnormal standard conditions Fig. 2 with image from Albertson et al., 2007
ventral mandibular arch malformed, abnormal standard conditions Fig. 2 with image,  Fig. 5 with image from Albertson et al., 2007

CITATIONS  (9)

Your Input Welcome
We welcome your input and comments. Please use this form to recommend updates to the information in ZFIN. We appreciate as much detail as possible and references as appropriate. We will review your comments promptly.
Please check the highlighted fields and try again.
Thank you for submitting comments. Your input has been emailed to ZFIN curators who may contact you if additional information is required.
Oops. Something went wrong. Please try again later.